Anna Kajaste-Rudnitski
Anna Kajaste-Rudnitski
San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Milan
Geverifieerd e-mailadres voor hsr.it - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
A variant in the CD209 promoter is associated with severity of dengue disease
A Sakuntabhai, C Turbpaiboon, I Casadémont, A Chuansumrit, ...
Nature genetics 37 (5), 507-513, 2005
3662005
TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation
A Di Pietro, A Kajaste-Rudnitski, A Oteiza, L Nicora, GJ Towers, N Mechti, ...
Journal of virology 87 (8), 4523-4533, 2013
1792013
The 2′, 5′-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells
A Kajaste-Rudnitski, T Mashimo, MP Frenkiel, JL Guénet, M Lucas, ...
Journal of Biological Chemistry 281 (8), 4624-4637, 2006
1192006
TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-κB-responsive long terminal repeat elements
A Kajaste-Rudnitski, SS Marelli, C Pultrone, T Pertel, PD Uchil, N Mechti, ...
Journal of virology 85 (10), 5183-5196, 2011
1042011
Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy
E Zonari, G Desantis, C Petrillo, FE Boccalatte, MR Lidonnici, ...
Stem cell reports 8 (4), 977-990, 2017
972017
Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progression
G Escobar, D Moi, A Ranghetti, P Ozkal-Baydin, ML Squadrito, ...
Science translational medicine 6 (217), 217ra3-217ra3, 2014
802014
Genetic Engineering of Hematopoiesis for Targeted IFN-a Delivery Inhibits Breast Cancer Progression
G Escobar, D Moi, A Ranghetti, P Ozkal-Baydin, ML Squadrito, ...
80*
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis
M Chiriaco, G Farinelli, V Capo, E Zonari, S Scaramuzza, G Di Matteo, ...
Molecular Therapy 22 (8), 1472-1483, 2014
642014
HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter
F Turrini, S Marelli, A Kajaste-Rudnitski, M Lusic, C Van Lint, AT Das, ...
Retrovirology 12 (1), 1-8, 2015
562015
Cyclosporin a and rapamycin relieve distinct lentiviral restriction blocks in hematopoietic stem and progenitor cells
C Petrillo, D Cesana, F Piras, S Bartolaccini, L Naldini, E Montini, ...
Molecular Therapy 23 (2), 352-362, 2015
542015
M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication
L Cassetta, A Kajaste-Rudnitski, T Coradin, E Saba, G Della Chiara, ...
Aids 27 (12), 1847-1856, 2013
502013
Cyclosporine H overcomes innate immune restrictions to improve lentiviral transduction and gene editing in human hematopoietic stem cells
C Petrillo, LG Thorne, G Unali, G Schiroli, AMS Giordano, F Piras, ...
Cell Stem Cell 23 (6), 820-832. e9, 2018
492018
Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals
A Kajaste-Rudnitski, L Galli, S Nozza, G Tambussi, A Di Pietro, ...
Aids 25 (2), 177-183, 2011
442011
Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′, 5′-oligoadenylate synthetase 1b
E Mertens, A Kajaste-Rudnitski, S Torres, A Funk, MP Frenkiel, I Iteman, ...
Virology 399 (1), 176-185, 2010
382010
Lipid-based nanoparticles as nonviral gene delivery vectors
D Pezzoli, A Kajaste-Rudnitski, R Chiesa, G Candiani
Nanomaterial Interfaces in Biology, 269-279, 2013
362013
Cellular innate immunity and restriction of viral infection: implications for lentiviral gene therapy in human hematopoietic cells
A Kajaste-Rudnitski, L Naldini
Human gene therapy 26 (4), 201-209, 2015
332015
Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells
F Piras, M Riba, C Petrillo, D Lazarevic, I Cuccovillo, S Bartolaccini, ...
EMBO molecular medicine 9 (9), 1198-1211, 2017
282017
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide
D Pinna, P Oreste, T Coradin, A Kajaste-Rudnitski, S Ghezzi, G Zoppetti, ...
Antimicrobial agents and chemotherapy 52 (9), 3078-3084, 2008
272008
A dimerizable cationic lipid with potential for gene delivery
G Candiani, D Pezzoli, M Cabras, S Ristori, C Pellegrini, ...
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2008
252008
Inhibition of influenza H5N1 invasion by modified heparin derivatives
MA Skidmore, A Kajaste-Rudnitski, NM Wells, SE Guimond, TR Rudd, ...
MedChemComm 6 (4), 640-646, 2015
222015
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20